Research Projects

This database contains information on EU funded dementia research projects, undertaken since 2007. It is the product of a mapping exercise of European funding programmes for dementia research conducted by Alzheimer Europe in 2020. This database is not an exhaustive resource of information. It contains information about dementia research projects that are funded by European programmes including FP7, H2020, IMI, JPND, AAL and the third EU Health programme. The mapping exercise and database were expanded in 2025, to include projects funded under Horizon Europe (including IHI). For these projects, the database reports the maximum contribution from the European Commission rather than the total project budget, so funding figures may not be directly comparable across all entries.
For an overview of projects, Alzheimer Europe is involved in, visit: https://www.alzheimer-europe.org/our-work/current-work

Filters

(Clear all)

The biofabrication of a 3D in vitro human oviduct model to study infertility and factors affecting embryo development

OviChip

Despite being viewed as a simple transport conduit, the oviduct can determine a successful pregnancy and has a life-long impact on our health and wellbeing. Also called the fallopian tube, our understanding of tubal function remains limited, owing to the ethical limitations of human studies and the poor translations of animal studies to people. The...

Funding Programme
Start Date
End Date
Total Funding
€ 2 318 530
European Countries Involved

The contribution of thalamocortical projections to high cognitive functions (speech processing, working memory and attention) in sighted and unsighted populations

THALABLIND

The proposed project aims to investigate the contribution of thalamocortical projections to high cognitive functions such as speechprocessing, working memory and attention in sighted and unsighted populations. In the last decades, advances made in magneticresonance imaging (MRI) have shed light on the cortical regions subserving these processes...

Funding Programme
Start Date
End Date
Total Funding
€ 181 152
European Countries Involved

The Ethics of Loneliness and Sociability

Ethics of Loneliness

Loneliness, which can be defined as the negative mental states (e.g. sadness, despair) that people experience when they feel that they do not have enough relationships, or not the right kinds of relationships, is a widespread phenomenon in many societies. Even prior to the current pandemic, surveys from Europe and North-America reported that 20 to...

Funding Programme
Start Date
End Date
Total Funding
€ 1 025 860
European Countries Involved

The missing mathematical story of Bayesian uncertainty quantification for big data

BigBayesUQ

Recent years have seen a rapid increase in available information. This has created an urgent need for fast statistical and machine learning methods that can scale up to big data sets. Standard approaches, including the now routinely used Bayesian methods, are becoming computationally infeasible, especially in complex models with many parameters and...

Funding Programme
Start Date
End Date
Total Funding
€ 1 492 750
European Countries Involved

The Neural Correlates of Object Location Memory

NeuraCOLM

Remembering where things are, for example, where you parked your car, is essential in everyday life. Without spatial memory, we would continuously be engaged in looking for our car, keys, phone, or glasses. Despite its obvious importance, a lot is still unknown about object location memory (OLM). This proposal aims to uncover mechanisms underlying...

Funding Programme
Start Date
End Date
Total Funding
€ 203 464
European Countries Involved

The origin and impact of impaired ubiquitin signaling in the degeneration of neurons

Ubi-Wan

Neurodegenerative diseases share similar hallmarks such as protein aggregation, suggesting that impaired protein degradation may be a common denominator. The major cellular pathways mediating protein degradation are the Ubiquitin-proteasome system (UPS) and autophagy, both regulated by ubiquitin signaling. However, aside from specific mutations in...

Funding Programme
Start Date
End Date
Total Funding
€ 2 500 000
European Countries Involved

The ProM platform: New ways to drug the undruggable

ProM

Existing pharmaceutical methods can only target 15% of all proteins in the human proteome. Given this limitation, pharmaceutical companies are running out of options to develop effective drugs to tackle hard-to-treat diseases. To have a better chance of fighting these diseases, further targets of the remaining, so far undruggable 85% of our...

Funding Programme
Start Date
End Date
Total Funding
€ 2 461 375
European Countries Involved

The role of eEF1A in synapse function, maintenance, and synucleinopathy

EaSYFUN

Synucleinopathies are neurodegenerative conditions characterized by an accumulation of the protein alpha-synuclein, including Parkinson's disease and dementia with Lewy bodies. A long asymptomatic phase precedes the onset of invalidating symptoms. Early diagnostics and treatments are hampered by an incomplete understanding of the pathophysiological...

Funding Programme
Start Date
End Date
Total Funding
€ 235 853
European Countries Involved

The Silent Phase of Alzheimer’s Disease: From Brain States to Homeostatic Failures

DormantAD

Neuronal circuits must balance stability and plasticity. How this balance is compromised in brain disorders remains one of the most fundamental questions in neuroscience. Pioneering studies in the field established that homeostatic mechanisms stabilize the function of a system at a set-point level of activity. Recently, we have identified bona fide...

Funding Programme
Start Date
End Date
Total Funding
€ 2 500 000
European Countries Involved

Towards an Integrative Model of the Relationship Between Episodic Memory and Novelty Detection Through a Behavioural and Neuropsychological Approach

DENOVO

"As memorizing new information relies on distinguishing the new from the familiar, novelty detection is closely tied to memory. Yet, the exact nature of this link remains unclearare they two sides of the same function or rather distinct yet interacting processes? Critically, there are different types of novelty: absolute (new stimulus) or...

Funding Programme
Start Date
End Date
Total Funding
€ 175 920
European Countries Involved

Towards high-affinity ligands for orphan receptors GPR3, GPR6 & GPR12

ToBeLi-for-GPR3-6-12

The family of G protein-coupled receptors (GPCRs) comprises more than 800 human cell surface receptors that perceive and transmit extracellular stimuli into the cell interior. Due to their involvement in numerous biochemical processes, GPCRs represent prime targets for the treatment of various diseases and are modulated by more than 30% of approved...

Funding Programme
Start Date
End Date
Total Funding
€ 189 687
European Countries Involved

Towards the clinical implementation of TREM2 Microglia Engineering for treating DementiaS

TREM2MEDS

TREM2MEDS emerges from the ERC PoC 2022 project TREM2ENGINES (Grant agreement ID: 101069395), which validated the efficacy of a novel treatment for Alzheimers Disease (AD) and Nasu-Hakola Disease (NHD) in murine models. A relevant proportion of AD cases and all forms of NHD are caused by pathogenic mutations in the TREM2 gene, which lead to...

Funding Programme
Start Date
End Date
Total Funding
€ 2 499 721
European Countries Involved
 
Acknowledgement
Alzheimer Europe's database on research projects was developed as part of the 2020 Work Plan which received funding under an operating grant from the European Union’s Health Programme (2014–2020).